Your browser doesn't support javascript.
loading
Antitumor Effects of Pan-RAF Inhibitor LY3009120 Against Lung Cancer Cells Harboring Oncogenic BRAF Mutation.
Miyauchi, Shunsaku; Shien, Kazuhiko; Takeda, Tatsuaki; Araki, Kota; Nakata, Kentaro; Miura, Akihiro; Takahashi, Yuta; Kurihara, Eisuke; Ogoshi, Yusuke; Namba, Kei; Suzawa, Ken; Yamamoto, Hiromasa; Okazaki, Mikio; Soh, Junichi; Tomida, Shuta; Yamane, Masaomi; Sakaguchi, Masakiyo; Toyooka, Shinichi.
Afiliación
  • Miyauchi S; Department of General Thoracic, Breast, and Endocrinological Surgery, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, Okayama, Japan.
  • Shien K; Department of General Thoracic, Breast, and Endocrinological Surgery, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, Okayama, Japan k.shien@okayama-u.ac.jp.
  • Takeda T; Department of Clinical Pharmacy, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, Okayama, Japan.
  • Araki K; Department of General Thoracic, Breast, and Endocrinological Surgery, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, Okayama, Japan.
  • Nakata K; Department of General Thoracic, Breast, and Endocrinological Surgery, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, Okayama, Japan.
  • Miura A; Department of General Thoracic, Breast, and Endocrinological Surgery, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, Okayama, Japan.
  • Takahashi Y; Department of General Thoracic, Breast, and Endocrinological Surgery, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, Okayama, Japan.
  • Kurihara E; Department of General Thoracic, Breast, and Endocrinological Surgery, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, Okayama, Japan.
  • Ogoshi Y; Department of General Thoracic, Breast, and Endocrinological Surgery, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, Okayama, Japan.
  • Namba K; Department of General Thoracic, Breast, and Endocrinological Surgery, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, Okayama, Japan.
  • Suzawa K; Department of General Thoracic, Breast, and Endocrinological Surgery, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, Okayama, Japan.
  • Yamamoto H; Department of General Thoracic, Breast, and Endocrinological Surgery, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, Okayama, Japan.
  • Okazaki M; Department of General Thoracic, Breast, and Endocrinological Surgery, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, Okayama, Japan.
  • Soh J; Department of General Thoracic, Breast, and Endocrinological Surgery, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, Okayama, Japan.
  • Tomida S; Center for Comprehensive Genomic Medicine, Okayama University Hospital, Okayama, Japan.
  • Yamane M; Department of General Thoracic, Breast, and Endocrinological Surgery, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, Okayama, Japan.
  • Sakaguchi M; Department of Cell Biology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, Okayama, Japan.
  • Toyooka S; Department of General Thoracic, Breast, and Endocrinological Surgery, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, Okayama, Japan.
Anticancer Res ; 40(5): 2667-2673, 2020 May.
Article en En | MEDLINE | ID: mdl-32366411
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Oncogenes / Compuestos de Fenilurea / Pirimidinas / Proteínas Proto-Oncogénicas B-raf / Inhibidores de Proteínas Quinasas / Neoplasias Pulmonares / Mutación / Antineoplásicos Límite: Animals / Female / Humans Idioma: En Revista: Anticancer Res Año: 2020 Tipo del documento: Article País de afiliación: Japón Pais de publicación: Grecia
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Oncogenes / Compuestos de Fenilurea / Pirimidinas / Proteínas Proto-Oncogénicas B-raf / Inhibidores de Proteínas Quinasas / Neoplasias Pulmonares / Mutación / Antineoplásicos Límite: Animals / Female / Humans Idioma: En Revista: Anticancer Res Año: 2020 Tipo del documento: Article País de afiliación: Japón Pais de publicación: Grecia